Abstract
Acute leukemia, secondary myelodysplasia and paroxysmal nocturnal hemoglobinuria evolving from severe aplastic anemia (AA) following immunosuppressive therapy are well recognized. However, severe AA occurring after complete remission of acute promyelocytic leukemia (APL) has been documented only once in 2009. We report a case of 30-year-old male diagnosed with APL who achieved complete cytogenetic remission with all-trans retinoic acid based induction regimen and developed severe AA few months later during maintenance therapy.
This is a preview of subscription content, log in via an institution to check access.
References
Wang ZY, Chen Z (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111(5):2505–2515
Tallman MS, Andersen JW, Schiffer CA et al (2002) All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 100(13):4298–4302
Tooze JA, Marsh JC, Gordon-Smith EC (1999) Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria. Leuk Lymphoma 33(3–4):231–241
Brodsky RA, Jones RJ (2004) Riddle: what do aplastic anaemia, acute promyelocytic leukemia, and chronic myeloid leukemia have in common? Leukemia 18(10):1740–1742
Pham A, Bahadini B, Alsabeh R et al (2009) First reported case of aplastic anemia occurring in a patient after acute promyelocytic leukemia in remission. Clin Adv Hematol Oncol 7(10):670–674
Young NS (2002) Acquired aplastic anemia. Ann Intern Med 136(7):534–546
Wernig G, Gilliland DG (2009) Pathobiology of acute myeloid leukemia. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Siberstein LE, McGlove P (eds) Hematology basic principles and practice, 5th edn. Elseiver, Philadelphia, pp 921–932
Teo JT, Klaassen R, Fernandez CV et al (2008) Clinical and genetic analysis of unclassifiable inherited bone marrow failure syndromes. Pediatrics 122(1):e139–e148
Barrett J, Saunthararajah Y, Molldrem J (2003) Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol 37(1):15–29
Lobe I, Rigal-Huguet F, Vekhoff A et al (2003) Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia 17(8):1600–1604
Singh ZN, Huo D, Anastasi J et al (2007) Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol 127:197–205
Katsanos KH, Tsianos EV (2007) Azathioprine/6-mercaptopurine toxicity: the role of the TPMT gene. Ann gastroenterol 20(4):251–264
Nabhan C, Radhakrishnan A (2009) Aplastic anemia surfacing after treatment of acute promyelocytic leukemia: the Dameshek riddle. Clin Adv Hematol Oncol 7(10):672–764
Latagliata R, Petti MC, Fenu S et al (2002) Therapy-related myelodysplastic syndrome- acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood 99(3):822–824
Dameshek W (1967) Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and “hypoplastic” leukemia have in common? Blood 30(2):251–254
Nissen C, Stern M (2009) Acquired immune mediated aplastic anemia: is it antineoplastic? Autoimmun Rev 9(1):11–16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Handigund, R.S., Malur, P.R., Dhumale, A.J. et al. Severe Aplastic Anemia Manifesting After Complete Remission of Acute Promyelocytic Leukemia: Is it a Fortuitous Association?. Indian J Hematol Blood Transfus 30, 64–67 (2014). https://doi.org/10.1007/s12288-012-0201-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-012-0201-8